These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 22690482)
1. [Targeted therapy in inflammatory disease: cytokines]. von Frenckell C; Malaise MG Rev Med Liege; 2012; 67 Spec No():22-8. PubMed ID: 22690482 [TBL] [Abstract][Full Text] [Related]
2. [Treatment of inflammation with anti-inflammatory cytokines: example in models of auto-immune diseases]. Bessis N; Fradelizi D; Fournier C; Boissier MC C R Seances Soc Biol Fil; 1995; 189(4):579-90. PubMed ID: 8564571 [TBL] [Abstract][Full Text] [Related]
3. Modern anti-cytokine therapy of autoimmune diseases. Astrakhantseva IV; Efimov GA; Drutskaya MS; Kruglov AA; Nedospasov SA Biochemistry (Mosc); 2014 Dec; 79(12):1308-21. PubMed ID: 25716724 [TBL] [Abstract][Full Text] [Related]
4. Small molecule approaches to treat autoimmune and inflammatory diseases (Part III): Targeting cytokines and cytokine receptor complexes. Zheng J; Chen D; Xu J; Ding X; Wu Y; Shen HC; Tan X Bioorg Med Chem Lett; 2021 Sep; 48():128229. PubMed ID: 34214508 [TBL] [Abstract][Full Text] [Related]
7. Immune therapies of autoimmune diseases: are we approaching a real cure? Chatenoud L Curr Opin Immunol; 2006 Dec; 18(6):710-7. PubMed ID: 17011768 [TBL] [Abstract][Full Text] [Related]
8. Cytokine inhibitors in rheumatoid arthritis and other autoimmune diseases. Williams RO; Paleolog E; Feldmann M Curr Opin Pharmacol; 2007 Aug; 7(4):412-7. PubMed ID: 17627887 [TBL] [Abstract][Full Text] [Related]
9. [Pathophysiological advances underlying the biotherapeutic revolution in inflammatory rheumatism]. Mariette X Bull Acad Natl Med; 2012 Oct; 196(7):1261-76; discussion 1276-8. PubMed ID: 23815013 [TBL] [Abstract][Full Text] [Related]
11. Newer targeted therapies in psoriasis. Khandpur S; Bhari N Indian J Dermatol Venereol Leprol; 2013 Jul; 79 Suppl 7():S47-52. PubMed ID: 23974694 [TBL] [Abstract][Full Text] [Related]
12. [Monoclonal antibodies in chronic autoimmune inflammatory diseases]. Semerano L; Boissier MC Med Sci (Paris); 2009 Dec; 25(12):1108-12. PubMed ID: 20035687 [TBL] [Abstract][Full Text] [Related]
13. Targeting interleukin-6 in inflammatory autoimmune diseases and cancers. Yao X; Huang J; Zhong H; Shen N; Faggioni R; Fung M; Yao Y Pharmacol Ther; 2014 Feb; 141(2):125-39. PubMed ID: 24076269 [TBL] [Abstract][Full Text] [Related]
14. Acting on the cytokine balance to control auto-immunity and chronic inflammation. Miossec P Eur Cytokine Netw; 1993; 4(4):245-51. PubMed ID: 8268414 [No Abstract] [Full Text] [Related]
15. Implications of anti-cytokine therapy in colorectal cancer and autoimmune diseases. Wang K; Grivennikov SI; Karin M Ann Rheum Dis; 2013 Apr; 72 Suppl 2():ii100-3. PubMed ID: 23253923 [TBL] [Abstract][Full Text] [Related]
16. [Role of monoclonal antibodies in the treatment of immune-mediated kidney disease: the state of the art]. Cravedi P G Ital Nefrol; 2012; 29(3):274-82; discussion 292. PubMed ID: 22718450 [TBL] [Abstract][Full Text] [Related]
17. Induction of protective therapy for autoimmune diseases by targeted DNA vaccines encoding pro-inflammatory cytokines and chemokines. Karin N Curr Opin Mol Ther; 2004 Feb; 6(1):27-33. PubMed ID: 15011778 [TBL] [Abstract][Full Text] [Related]
18. Drug targets in the cytokine universe for autoimmune disease. Liu X; Fang L; Guo TB; Mei H; Zhang JZ Trends Immunol; 2013 Mar; 34(3):120-8. PubMed ID: 23116550 [TBL] [Abstract][Full Text] [Related]
19. Agents against cytokine synthesis or receptors. Yamagata T; Ichinose M Eur J Pharmacol; 2006 Mar; 533(1-3):289-301. PubMed ID: 16457805 [TBL] [Abstract][Full Text] [Related]
20. Trends in the development of therapeutic anti-cytokine antibodies. Reichert JM Drug Discov Today; 2004 Apr; 9(8):348. PubMed ID: 15081960 [No Abstract] [Full Text] [Related] [Next] [New Search]